Ignite Creation Date:
2025-12-24 @ 3:14 PM
Ignite Modification Date:
2026-01-02 @ 12:49 AM
Study NCT ID:
NCT00413192
Status:
COMPLETED
Last Update Posted:
2017-04-26
First Post:
2006-12-15
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
E7389 Administered as an IV Bolus Infusion Day 1 and Day 8 Every 3 Weeks in Pre-Treated Patients With Advanced and/or Metastatic Soft Tissue Sarcoma
Sponsor:
Eisai Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2007-01
Start Date Type:
None
Primary Completion Date:
2012-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-02
Completion Date Type:
ACTUAL
First Submit Date:
2006-12-15
First Submit QC Date:
None
Study First Post Date:
2006-12-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-02-02
Results First Submit QC Date:
None
Results First Post Date:
2017-03-22
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-03-27
Last Update Post Date:
2017-04-26
Last Update Post Date Type:
ACTUAL